generic pharma start-up competitive on day one

The subsidiary of a global pharmaceutical company entering hyper-competitive U.S. generic pharmaceuticals market but lacking efficient supply chain infrastructure to operate profitably

• The generics industry is a never-ending race between multiple international manufacturers competing on all levels: price, supply, patent challenging, and exclusivity
• New companies need to coordinate successful product launches while establishing effective and efficient operations

The company leverages DDN’s extensive experience launching startups and products for its U.S. market entry, gradually expanding to incorporate a full range of supply chain services

• Initially outsourcing a handful of operational functions to DDN, the company has grown to rely on DDN for warehousing, distribution, chargebacks, EDI, invoicing and accounts receivable, Medicare/Medicaid, strategic collaboration and more

The company enters the U.S. market and is immediately competitive with market veterans, setting stage for profitability and growth

• The company connects to clients via stocking and financial relationships managed by DDN, allowing it to focus on growth through new product filings and trade relations
• Therapeutic categories addressed by the company’s growing product line include cardiovascular, asthma, and psychiatric
• The company became an industry competitor without first having to develop facilities, systems, and workforce
• Advanced, efficient infrastructure gives company competitive advantage relative to others taking the same products to market